Study title and authors:
Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TEXCAPS): additional perspectives on tolerability of long-term treatment with lovastatin.
This study can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/11348605
This study examined the effects of 20 to 40 mg/day of lovastatin in 6,605 generally healthy middle-aged and older men and women. 3,304 people received the statin drug and 3,301 people received a placebo.
The study found that the statin drug reduced the risk of a first acute major coronary event by 37%. However the statin drug also increased cancer rates by 41% and increased the overall death rate by 4%.
More information on this subject: Books : Scientific Studies : Other Websites : Videos : Food Mall